UnknownPhase 3NCT04618640
To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years
Studying Diphtheria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boryung Biopharma Co., Ltd.
- Principal Investigator
- Byeonguk EunEulji University Hospital
- Intervention
- DTaP-IPV combination vaccine(biological)
- Enrollment
- 249 enrolled
- Eligibility
- 4-6 years · All sexes
- Timeline
- 2019 – 2021
Study locations (26)
- Korea University Ansan Hospital, Ansan, South Korea
- Hallym University Medical Center, Anyang, South Korea
- Changwon Fatima Hospital, Changwon, South Korea
- KeiMyung University Dongsan Medical Center, Daegu, South Korea
- Hallym University Medical Center, Gyeonggi-do, South Korea
- Myongji Hospital, Gyeonggi-do, South Korea
- Wonkwang University Hospital, Iksan, South Korea
- Inha University Hospital, Incheon, South Korea
- The Catholic University of Korea Incheon St. Mary's Hospital, Incheon, South Korea
- Jeonbuk National University Hospital, Jeonju, South Korea
- Mediplex Sejong Hospital, Sejong, South Korea
- Bundang Cha Hospital, Seongnam, South Korea
- Asan Medical Center, Seoul, South Korea
- Chung-Ang University Hospital, Seoul, South Korea
- Eulji University Hospital, Seoul, South Korea
- +11 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04618640 on ClinicalTrials.govOther trials for Diphtheria
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07203755Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined VaccineCanSino Biologics Inc.
- RECRUITINGPHASE4NCT07097012Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in PregnancyCanadian Immunization Research Network
- RECRUITINGPHASE3NCT07112144Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical TrialChangchun BCHT Biotechnology Co.
- RECRUITINGPHASE1, PHASE2NCT06997627A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy AdultsGC Biopharma Corp
- RECRUITINGNANCT06815250Enhancing Maternal Vaccine Knowledge and Uptake: the InTroDuce-Programme TrialUniversiti Putra Malaysia
- RECRUITINGPHASE2, PHASE3NCT06947499A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesLG Chem
- ENROLLING BY INVITATIONPHASE4NCT07005726BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in AfricaBandim Health Project
- ACTIVE NOT RECRUITINGPHASE3NCT06857370Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined VaccineCanSino Biologics Inc.